The effect of therapeutic potential and safety of bone marrow-derived against adipose-derived mesenchymal stem cells in aged mice associated with septic arthritis.
Khalid Ahmed AM., Khalaf Ali M., Kh Alani B.
Animal Study with a reported sample of 9 on Cartilage Damage, published in PLoS One (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- PLoS One (2025)
- Country
- United States
- Reported sample size
- 9
- Source database
- PubMed
- PMID
- 41296765
- PMCID
- PMC12654889
- DOI
- 10.1371/journal.pone.0335011
- Citations
- 1
Abstract (original English)
Mesenchymal stem cells (MSCs) show potential for treating septic arthritis in aged populations, but their efficacy and safety in aged patients remain unclear. The objective of this study is to evaluate the therapeutic potential and safety profiles of bone marrow-derived MSCs (BM-MSCs) and adipose-derived MSCs (AD-MSCs) in aged murine model of septic arthritis. MSCs were isolated, characterized, and labeled for in vivo tracking. The experiment consisted of a total of 36 mice, which included 9 subgroups with four replicates per treated group: control group, treated groups (BM-MSC1, BM-MSC2, AD-MSC1, and AD-MSC2), and untreated groups (Un-BM1, Un-BM2, Un-AD1, and Un-AD2). The treated groups received MSC therapy following the induction of septic arthritis via intra-articular injection of Staphylococcus aureus. The results showed that BM-MSC1 significantly performed higher than AD-MSCs in reducing inflammation, promoting cartilage repair, and modulating immune responses. BM-MSC1 showed significant upregulation of regenerative markers such as interleukin-10 (IL-10) and collagen type II alpha 1 chain (COL2A1) and downregulation of pro-inflammatory markers such as tumor necrosis factor-alpha (TNF-a) and matrix metalloproteinase-13 (MMP-13). Imaging confirmed superior retention, engraftment, and host tissue interaction for BM-MSCs. AD-MSCs showed slightly lower efficacy and safety, high
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
A Systematic Review on Amnion as a Cell Delivery Scaffolding Material for Cartilage Regeneration in Pre-Clinical and Clinical Studies.
Systematic Review on Osteoarthritis, Cartilage Damage, published in Bioengineering (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Bioengineering (Basel)1 citations - Level ASystematic ReviewPubMed
Intra-articular adipose-derived cell therapies for knee osteoarthritis: a systematic review of randomized controlled trials.
Systematic Review on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Med (Lausanne) - Level ASystematic ReviewEurope PMC
Subchondral Knee Injections: A Comprehensive Systematic Review of Current Clinical Outcomes, Safety, and Arthroplasty Delay
Systematic Review with a reported sample of 5 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Cartilage (2026) — summary generated from the PubMed abstract.
- 2026
- n = 5
Cartilage - Level AMeta-analysisEurope PMC
Mesenchymal stem cell-derived extracellular vesicles for osteochondral defect regeneration: a systematic review and meta-analysis of preclinical studies
Meta-analysis on Cartilage Damage, published in J Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
J Transl Med - Level ASystematic ReviewEurope PMC
The role of costal cartilage in musculoskeletal regeneration: A systematic review
Systematic Review on Cartilage Damage, published in J Exp Orthop (2026) — summary generated from the PubMed abstract.
- 2026
J Exp Orthop - Level ASystematic ReviewPubMed
A Comparison of the Properties of Mesenchymal Stem Cells Derived from Different Synovial Sources: A Systematic Review.
Systematic Review on Osteoarthritis, Cartilage Damage, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci